Skip to main content
NCBI home page
The Canadian Veterinary Journal logoLink to The Canadian Veterinary Journal
. 1993 May;34(5):296–300.

Clinical effects of detomidine with or without atropine used for arthrocentesis in horses

Diana L Jones
PMCID: PMC1686527  PMID: 17424223

Abstract

The effectiveness of detomidine with or without atropine sulfate premedication in producing sedation and analgesia for arthrocentesis was studied in 12 horses. The effects were evaluated by monitoring heart and respiratory rates, borborygmi, distance from the lower lip to the floor, systolic blood pressure, and response to needle insertion. Either atropine or saline (as a placebo) was administered immediately prior to detomidine. All drugs were administered intravenously. Measurements were taken prior to drug injection and at 1, 5, 10, 15, 20, 25, 30, 40, 50, 60, 120, 180 and 240 minutes postinjection. Detomidine with atropine resulted in significantly higher heart rates than detomidine without atropine for the three hours of observation. Borborygmi were significantly decreased for four hours following detomidine with atropine and for three hours following detomidine without atropine, when compared to preinjection levels. Systolic blood pressure was significantly increased for 15 minutes following detomidine and atropine compared to the preinjection level. The head was markedly lowered for 60 minutes with either treatment. Atropine prevented the bradyarrhythmia and bradycardia induced by detomidine, but it induced a tachycardia. A satisfactory response for needle insertion and adequate synovial fluid aspiration was achieved in 95% of the trials with detomidine, with or without atropine sulfate premedication. The results suggest that, although atropine prevents bradyarrhythmia and bradycardia following detomidine, administering detomidine without atropine is satisfactory for arthrocentesis in untrained horses.

Full text

PDF
296

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Alitalo I., Vainio O., Kaartinen L., Raekallio M. Cardiac effects of atropine premedication in horses sedated with detomidine. Acta Vet Scand Suppl. 1986;82:131–136. [PubMed] [Google Scholar]
  2. Gasthuys F., De Moor A., Parmentier D. Haemodynamic changes during sedation in ponies. Vet Res Commun. 1990;14(4):309–327. doi: 10.1007/BF00350713. [DOI] [PubMed] [Google Scholar]
  3. Jöchle W., Hamm D. Sedation and analgesia with Domosedan (detomidine hydrochloride) in horses: dose response studies on efficacy and its duration. Acta Vet Scand Suppl. 1986;82:69–84. [PubMed] [Google Scholar]
  4. Kerr D. D., Jones E. W., Huggins K., Edwards W. C. Sedative and other effects of xylazine given intravenously to horses. Am J Vet Res. 1972 Mar;33(3):525–532. [PubMed] [Google Scholar]
  5. Kokkonen U. M., Eriksson L. Cardiovascular and allied actions of xylazine and atropine in the unanaesthetized goat. J Vet Pharmacol Ther. 1987 Mar;10(1):11–16. doi: 10.1111/j.1365-2885.1987.tb00070.x. [DOI] [PubMed] [Google Scholar]
  6. Lammintausta R. Introduction to adrenoceptor pharmacology. Acta Vet Scand Suppl. 1986;82:11–16. [PubMed] [Google Scholar]
  7. Maze M., Tranquilli W. Alpha-2 adrenoceptor agonists: defining the role in clinical anesthesia. Anesthesiology. 1991 Mar;74(3):581–605. [PubMed] [Google Scholar]
  8. Reitemeyer H., Klein H. J., Deegen E. The effect of sedatives on lung function in horses. Acta Vet Scand Suppl. 1986;82:111–120. [PubMed] [Google Scholar]
  9. Roger T., Ruckebusch Y. Colonic alpha 2-adrenoceptor-mediated responses in the pony. J Vet Pharmacol Ther. 1987 Dec;10(4):310–318. doi: 10.1111/j.1365-2885.1987.tb00107.x. [DOI] [PubMed] [Google Scholar]
  10. Ruskoaho H. Subtypes and functions of alpha-adrenoceptors. Acta Vet Scand Suppl. 1986;82:17–28. [PubMed] [Google Scholar]
  11. Salonen J. S. Pharmacokinetics of detomidine. Acta Vet Scand Suppl. 1986;82:59–66. [PubMed] [Google Scholar]
  12. Salonen J. S., Vähä-Vahe T., Vainio O., Vakkuri O. Single-dose pharmacokinetics of detomidine in the horse and cow. J Vet Pharmacol Ther. 1989 Mar;12(1):65–72. doi: 10.1111/j.1365-2885.1989.tb00643.x. [DOI] [PubMed] [Google Scholar]
  13. Sarazan R. D., Starke W. A., Krause G. F., Garner H. E. Cardiovascular effects of detomidine, a new alpha 2-adrenoceptor agonist, in the conscious pony. J Vet Pharmacol Ther. 1989 Dec;12(4):378–388. doi: 10.1111/j.1365-2885.1989.tb00688.x. [DOI] [PubMed] [Google Scholar]
  14. Savola J. M. Cardiovascular actions of detomidine. Acta Vet Scand Suppl. 1986;82:47–57. [PubMed] [Google Scholar]
  15. Short C. E., Matthews N., Harvey R., Tyner C. L. Cardiovascular and pulmonary function studies of a new sedative/analgetic (detomidine/Domosedan) for use alone in horses or as a preanesthetic. Acta Vet Scand Suppl. 1986;82:139–155. [PubMed] [Google Scholar]
  16. Short C. E., Stauffer J. L., Goldberg G., Vainio O. The use of atropine to control heart rate responses during detomidine sedation in horses. Acta Vet Scand. 1986;27(4):548–559. doi: 10.1186/BF03548134. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Soldani G., Mengozzi G., Intorre L. Inhibition of gastric acid secretion in dogs by detomidine. J Vet Pharmacol Ther. 1987 Sep;10(3):266–268. doi: 10.1111/j.1365-2885.1987.tb00540.x. [DOI] [PubMed] [Google Scholar]
  18. Virtanen R. Pharmacology of detomidine and other alpha 2-adrenoceptor agonists in the brain. Acta Vet Scand Suppl. 1986;82:35–46. [PubMed] [Google Scholar]
  19. Wagner A. E., Muir W. W., 3rd, Hinchcliff K. W. Cardiovascular effects of xylazine and detomidine in horses. Am J Vet Res. 1991 May;52(5):651–657. [PubMed] [Google Scholar]
  20. Wood T., Weckman T., Woods W. E., Tobin T., Dougherty J. Detomidine: a preliminary analysis of its duration of action in the horse by variable interval responding. Equine Vet J. 1988 Sep;20(5):320–322. doi: 10.1111/j.2042-3306.1988.tb01535.x. [DOI] [PubMed] [Google Scholar]

Articles from The Canadian Veterinary Journal are provided here courtesy of Canadian Veterinary Medical Association

RESOURCES